The presence of MHC class II-restricted CD4+ T cells that are specific for tumor-associated antigens has been recognized as an important element for providing helper factors essential for eliciting and sustaining cytotoxic CD8+ responses against tumors [13, 14]. This evidence concerns the gene CD8A and neoplasm.